Assurans 20 mg Cipla

What Is Assurans 20mg Cipla? Assurans 20mg is a sildenafil citrate formulation manufactured by Cipla, a globally recognised pharmaceutical producer. Sildenafil citrate belongs to the phosphodiesterase type 5 (PDE5) inhibitor class, selectively targeting the PDE5 enzyme responsible for degrading cyclic guanosine monophosphate (cGMP) within smooth muscle tissue. By modulating cGMP breakdown, sildenafil supports the study of vasodilation pathways and nitric oxide (NO) signalling in vascular biology research contexts. Researchers and scientists sourcing from uksteroidshops.co.uk can access this compound as part of a broad catalogue of laboratory-grade research materials. Research Applications and Scientific Context Sildenafil citrate has an extensive published research history spanning cardiovascular physiology, pulmonary arterial hypertension models, and endothelial function studies. As a selective PDE5 inhibitor, it is widely utilised in preclinical investigations examining smooth muscle relaxation in arterial tissue and the interplay between NO pathways and haemodynamics. Researchers investigating sexual health compounds will also find the broader Viagra (Sildenafil) category on this site valuable for comparing related formulations and concentrations. Additionally, scientists working across adjacent areas of hormonal and anabolic research may cross-reference findings with compounds listed under oral steroids, where receptor-mediated pathways also play a central role. Each Assurans 20mg tablet from Cipla delivers a consistent 20 mg unit dose of sildenafil citrate, providing reproducible measurement units suitable for structured laboratory protocols. Cipla’s manufacturing reputation ensures formulation reliability, a key consideration when standardising experimental batches. Product Specifications Assurans 20mg Cipla — Technical Data Parameter Detail Compound Sildenafil Citrate Brand / Manufacturer Assurans / Cipla Strength per Unit 20 mg Class PDE5 Inhibitor CAS Number 171599-83-0 Molecular Formula C₂₂H₃₀N₆O₄S (free base) Molecular Weight 474.58 g/mol (free base) Form Oral tablet Storage Room temperature, dry, away from direct light SKU EU14112 Price £132 Compliance, Safety, and Legal Notice Researchers exploring the intersection of vascular pharmacology and metabolic research may also find reference material within our injectable steroids section, where haemodynamic and tissue-perfusion considerations are equally relevant to study design. Assurans 20mg Cipla is supplied strictly for laboratory research and scientific investigation purposes only. This product is not intended for human consumption, self-administration, or therapeutic use outside of appropriately regulated clinical settings. No information presented here constitutes medical advice or a prescription recommendation. Purchasers must be aged 18 or over and are solely responsible for compliance with all applicable local and national laws governing the acquisition and use of this compound. Always consult a qualified medical professional before handling any pharmacologically active substance.